论文部分内容阅读
室安卡因(Tocainide,W36095)是一种新型抗心律失常药。自1973年以来,有关的临床和实验研究已陆续报道。此药的抗心律失常作用与利多卡因相似,但可供口服,长期应用安全有效,是一种有前途的防治室性心律失常药物。我院内科自1980年4月至1981年8月,用山西省大同市制药厂试制的室安卡因治疗各种心律失常132例,其中除去室上性心律失常及静脉给药者外,其余113例室性期前收缩(以
Tocainide (W36095) is a new antiarrhythmic drug. Since 1973, the relevant clinical and experimental studies have been reported. The anti-arrhythmic effect of this drug is similar to that of lidocaine, but it is safe and effective for oral administration and long-term application. It is a promising drug for prevention and treatment of ventricular arrhythmia. Department of Internal Medicine in our hospital from April 1980 to August 1981, with Datong City, Shanxi Province trial of ventricular analgesia in a variety of ventricular arrhythmias 132 cases, of which except for supraventricular arrhythmias and intravenous administration, the rest 113 cases of ventricular contraction (to